Delcath Systems, Inc. (DCTH) P/E Ratio History
Historical price-to-earnings valuation from 2018 to 2026
Loading P/E history...
DCTH Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Delcath Systems, Inc. (DCTH) trades at a price-to-earnings ratio of 166.3x, with a stock price of $11.24 and trailing twelve-month earnings per share of $0.02.
The current P/E is 70% below its 5-year average of 553.8x. Over the past five years, DCTH's P/E has ranged from a low of 0.1x to a high of 1628.1x, placing the current valuation at the 50th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, DCTH trades at a 645% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, DCTH commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DCTH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DCTH P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $8B | 25.5 | 1.11 | -25% | |
| $2B | 6.9Lowest | 0.67Best | +817% | |
| $7B | 15.5 | - | +1747%Best | |
| $100B | 21.6 | - | +31% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
DCTH Historical P/E Data (2018–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $9.28 | $0.01 | 1628.1x | +194% | |
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $10.10 | $0.06 | 160.8x | -71% |
| FY2025 Q3 | $10.75 | $0.01 | 1235.6x | +123% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $13.60 | $0.05 | 298.2x | -46% |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $11.61 | $75.06 | 0.2x | -100% |
| FY2018 Q4 | Mon Dec 31 2018 00:00:00 GM | $196.00 | $1628.22 | 0.1x | -100% |
Average P/E for displayed period: 553.8x
See DCTH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DCTH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DCTH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDCTH — Frequently Asked Questions
Quick answers to the most common questions about buying DCTH stock.
Is DCTH stock overvalued or undervalued?
DCTH trades at 166.3x P/E, below its 5-year average of 553.8x. At the 50th percentile of historical range, the stock is priced at a discount to its own history.
How does DCTH's valuation compare to peers?
Delcath Systems, Inc. P/E of 166.3x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is DCTH's PEG ratio?
DCTH PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2018-2026.